-
Novo Nordisk Ultra Long acting Insulin Global First Batch Expected Within Two Months
[The first batch of Novo Nordisk ultra long-acting insulin in the world is expected to be within two months] A few days ago, the Commission on Human Medicines (CHMP) of the European Drug Administrati ... -
The first weekly long-acting hemophilia therapy has been approved by the FDA from Pfizer
On October 11th local time, the US FDA approved Pfizer's drug Hympavzi (marstalimab) for routine prevention or reduction of bleeding in adult and pediatric patients aged 12 and above with hemophilia ... -
Tianjing Biotechnology and Jichuan Pharmaceutical jointly announced that the application for marketing of Yitan long-acting growth hormone has been accepted
According to AI News, on December 9th, Tianjing Biotechnology and Jichuan Pharmaceutical jointly announced that the biological product marketing application (BLA) for the treatment of children with g ...